Skip to content

Canceled by the investigator. A prospective comparison of TL-400 and NICOM for goal-directed fluid therapy in gastrointestinal tumors surgery

A prospective comparison of TL-400 and NICOM for goal-directed fluid therapy in gastrointestinal tumors surgery

Status
Unknown
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046350
Enrollment
Unknown
Registered
2021-05-14
Start date
2021-06-01
Completion date
Unknown
Last updated
2022-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

GDFT for gastrointestinal tumor patients

Interventions

Group N :GDFT based on NICOM
Group T:GDFT based on TL-400

Sponsors

Yongchuan Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. The research object is patients who underwent laparoscopic gastrointestinal tumor resection in our hospital. Based on previous relevant statistical data, the sample size was calculated using PASS 15.0 software to be 75 patients; 2. The patient is informed, voluntarily, and agrees to participate. The patient himself or his family members sign the informed consent form before the operation, and the ASA classification is II to III.

Exclusion criteria

Exclusion criteria: 1. Patients with heart, liver, brain, lung, kidney, metabolic and central nervous system diseases, pregnancy, and those who are known to be allergic to the above-mentioned drugs; 2. Patients with insignificant radial artery pulsation, arteriovenous shunts, abnormal limb anatomy, and unable to perform TL-400 and NICOM measurements.

Design outcomes

Primary

MeasureTime frame
Intraoperative fluid flow;Hemodynamic index;postoperative complications;

Countries

China

Contacts

Public ContactLi Min

Yongchuan Hospital of Chongqing Medical University

1138268458@qq.com+86 13637857062

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026